Jeff Goater

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jessica Fees, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeff Goater:

Company Role Class Num Shares Value Price $ Report Date Ownership
VACCINEX, INC. Director Stock Option (Right to Buy) 28,586 $22,011 $0.7700 11 May 2021 Direct
VACCINEX, INC. Director Common Stock 300 $216 $0.7200 11 May 2021 Direct
LogicBio Therapeutics, Inc. Director Stock Option (right to buy) 0 16 Nov 2022 Direct
Surface Oncology, Inc. Director Common Stock 0 $0.9400 08 Sep 2023 Direct

Insider Reports Filed by Jeff Goater

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123048758-goater-jeff-2023-09-08 Surface Oncology, Inc. 08 Sep 2023 1 $0 4 Director 08 Sep 2023, 16:00
/report/000089924322036298-goater-jeff-2022-11-16 LogicBio Therapeutics, Inc. 16 Nov 2022 1 $0 4 Director 17 Nov 2022, 20:09
/report/000120919122038236-goater-jeff-2022-06-17 LogicBio Therapeutics, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 08:08
/report/000120919122036144-goater-jeff-2022-06-08 Surface Oncology, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 20:00
/report/000120919122003400-goater-jeff-2021-07-21 Surface Oncology, Inc. 21 Jul 2021 1 -$779,446 4 Director 14 Jan 2022, 19:30
/report/000120919121040429-goater-jeff-2021-06-11 LogicBio Therapeutics, Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 20:01
/report/000120919121040078-goater-jeff-2021-06-10 Surface Oncology, Inc. 10 Jun 2021 8 -$900,545 4 Director 11 Jun 2021, 20:30
VCNX VACCINEX, INC. 11 May 2021 1 $0 4 Director 12 May 2021, 16:27